Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia

Blood

Volumn 97, Issue 7, 2001, Pages 2115-2120

  Chen, Jiann Shiuh ^b   Coustan Smith, Elaine ^b   Suzuki, Toshio ^b   Neale, Geoffrey A ^b   Mihara, Keichiro ^b   Pui, Ching Hon ^b   Campana, Dario ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CALDESMON; CALPASTATIN; CALPHOBINDIN II; CD19 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; CREATINE KINASE ISOENZYME; IMMUNOGLOBULIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MYELOID NUCLEAR DIFFERENTIATION ANTIGEN; NINJURIN 1; PROTEIN HDJ1; PROTEIN REF1; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CANCER REGRESSION; CELL LINEAGE; CHILD; DNA HYBRIDIZATION; DNA MICROARRAY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN EXPRESSION;

EID: 0035313156     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.7.2115     Document Type: Article

References (52)

1. New definition of remission in childhood acute lymphoblastic leukemia
2. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
3. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia
4. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry
5. Clinical importance of minimal residual disease in childhood acute lymphobiastic leukemia
6. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
7. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
8. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
9. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome
10. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
11. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
12. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: Implications for the detection of minimal residual disease by polymerase chain reaction analysis
13. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia
14. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: Implication for a general strategy of minimal residual disease detection
15. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia
16. Detection of minimal residual disease in acute leukemia by flow cytometry
17. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
18. Examining the living genome in health and disease with DNA microarrays
19. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
20. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
21. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
22. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
23. Systematic variation in gene expression patterns in human cancer cell lines
24. Immunophenotyping
25. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics
26. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product
27. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age
28. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
29. Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays
30. The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression
31. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
32. In vivo gene expression profile analysis of human breast cancer progression
33. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells
34. Tissue- and cell-specific distribution of creatine kinase B: A new and highly specific monoclonal antibody for use in immunohistochemistry
35. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia
36. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection
37. Differential expression of Ca(2+)-binding proteins on follicular dendritic cells in non-neoplastic and neoplastic lymphoid follicles
38. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias
39. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3
40. Structure and expression of the human creatine kinase B gene
41. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth
42. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains
43. Calpain and calpastatin regulate neutrophil apoptosis
44. Cleavage of the calpain inhibitor, calpastatin, during apoptosis
45. Cloning of a unique human homologue of the Escherichia coli DNAJ heat shock protein
46. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
47. Annexin VI is required for budding of clathrin-coated pits
48. Immunophenotyping of leukemia
49. Drug therapy: Acute lymphoblastic leukemia
50. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
51. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts
52. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples